Bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P): Two dosing schedules of a novel phase I regimen in patients with relapsed/refractory indolent and mantle cell lymphomas Meeting Abstract

  

Authors:	Gerecitano, J.; Portlock, C.; Hamlin, P.; Moskowitz, C.; Noy, A.; Straus, D.; Zelenetz, A. D.; Schulman, P.; Dumitrescu, O.; O'Connor, O. A.
Abstract Title:	Bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P): Two dosing schedules of a novel phase I regimen in patients with relapsed/refractory indolent and mantle cell lymphomas
Meeting Title:	10th International Conference on Malignant Lymphoma
Journal Title:	Annals of Oncology
Volume:	19
Issue:	Suppl. 4
Meeting Dates:	2008 Jun 4-7
Meeting Location:	Lugano, Switzerland
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2008-06-01
Start Page:	213
End Page:	214
Language:	English
ACCESSION:	WOS:000256693500460
PROVIDER:	wos
DOI:	10.1093/annonc/mdn252
Notes:	--- - Meeting Abstract: 443 - 10th International Conference on Malignant Lymphoma - JUN 04-07, 2008 - Lugano, SWITZERLAND - "4" - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/24111